Literature DB >> 1898890

The use of biosynthetic human growth hormone to augment ovulation induction with buserelin acetate/human menopausal gonadotropin in women with a poor ovarian response.

Z H Ibrahim1, P L Matson, P Buck, B A Lieberman.   

Abstract

The present study has demonstrated the usefulness of GH in augmenting buserelin acetate/hMG to stimulate the rate of growth of follicles in women regarded as poor responders. The PR achieved was extremely encouraging in a group of patients whose prognosis was otherwise poor. Further studies are required to confirm these preliminary data.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1898890     DOI： 10.1016/s0015-0282(16)54084-9

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  14 in total

1.  Cessation of low-dose gonadotropin releasing hormone agonist therapy followed by high-dose gonadotropin stimulation yields a favorable ovarian response in poor responders.

Authors:  Pu-Tsui Wang; Robert Kuo-kuang Lee; Jin-Tsung Su; Jen-Wan Hou; Ming-Huei Lin; Yu-Ming Hu
Journal:  J Assist Reprod Genet       Date:  2002-01       Impact factor: 3.412

Review 2.  Growth hormone--a cogonadotropin? Its role in ovulation induction.

Authors:  Z Blumenfeld
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-06

3.  Follicular fluid insulin-like growth factor-I and insulin-like growth factor-binding protein-1 and -3 vary as a function of ovarian reserve and ovarian stimulation.

Authors:  L Stadtmauer; A Vidali; S R Lindheim; M V Sauer
Journal:  J Assist Reprod Genet       Date:  1998-11       Impact factor: 3.412

4.  The place of cotreatment with growth hormone and human menopausal gonadotropin (hMG) in ovarian stimulation.

Authors:  R Homburg; Z Ben-Rafael
Journal:  J Assist Reprod Genet       Date:  1996-05       Impact factor: 3.412

5.  In vitro fertilization with low-dose clomiphene citrate stimulation in women who respond poorly to superovulation.

Authors:  A O Awonuga; A Nabi
Journal:  J Assist Reprod Genet       Date:  1997-10       Impact factor: 3.412

Review 6.  Growth hormone cotreatment with gonadotropins in ovulation induction.

Authors:  P G Artini; A A de Micheroux; G D'Ambrogio
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

7.  The poor-responder patient in an in vitro fertilization-embryo transfer program.

Authors:  Z Ben-Rafael; D Feldberg
Journal:  J Assist Reprod Genet       Date:  1993-02       Impact factor: 3.412

8.  Does pretreatment with progestogen or oral contraceptive pills in low responders followed by the GnRHa flare protocol improve the outcome of IVF-ET?

Authors:  E al-Mizyen; L Sabatini; A M Lower; C M Wilson; T al-Shawaf; J G Grudzinskas
Journal:  J Assist Reprod Genet       Date:  2000-03       Impact factor: 3.412

9.  Interleukin-1 beta, interleukin-6, and growth hormone levels in human follicular fluid.

Authors:  C Huyser; F L Fourie; E Bosmans; P F Levay
Journal:  J Assist Reprod Genet       Date:  1994-04       Impact factor: 3.412

Review 10.  Different ovarian stimulation protocols for women with diminished ovarian reserve.

Authors:  D Loutradis; P Drakakis; E Vomvolaki; A Antsaklis
Journal:  J Assist Reprod Genet       Date:  2007-11-22       Impact factor: 3.412
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.